AbbVie (ABBV) Other Accumulated Expenses (2012 - 2015)

AbbVie (ABBV) has 4 years of Other Accumulated Expenses data on file, last reported at $2.5 billion in Q4 2015.

• Quarterly Other Accumulated Expenses rose 31.54% year-over-year to $2.5 billion in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $2.5 billion (up 31.54% YoY) and the FY2015 annual result came in at $2.5 billion, up 31.54% from the prior year.
• Other Accumulated Expenses climbed to $2.5 billion in Q4 2015 per ABBV's latest filing, from $1.9 billion in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $2.5 billion in Q4 2015 and bottomed at $1.5 billion in Q4 2013.
• The 4-year median for Other Accumulated Expenses is $1.8 billion (2012), against an average of $1.9 billion.
• The widest annual swing landed in 2013, when Other Accumulated Expenses retreated 10.88%; it then surged 31.54% in 2015.
• Tracing ABBV's Other Accumulated Expenses over 4 years: stood at $1.7 billion in 2012, then slipped by 10.88% to $1.5 billion in 2013, then gained by 26.32% to $1.9 billion in 2014, then surged by 31.54% to $2.5 billion in 2015.
• Per Business Quant, the three latest ABBV Other Accumulated Expenses figures stand at $2.5 billion (Q4 2015), $1.9 billion (Q4 2014), and $1.5 billion (Q4 2013).

Peer Comparison